CNE1000015N1
CNE1000015N1
D.A. DIAGNOSTICS
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 12.75B EUR | 11.71B EUR | 11.54B EUR | 9.91B EUR |
Enterprise Value | 14.84B EUR | 12.55B EUR | 12.39B EUR | 10.45B EUR |
Valuation Multiples | ||||
Trailing P/E | 46.36x | 53.31x | 138.99x | -- |
Forward P/E | 31.15x | -- | -- | -- |
Price to Sales | 1.28x | 1.6x | 1.57x | 1.33x |
Price to Book | 1.92x | 1.81x | 1.77x | 1.54x |
EV/Revenue | 1.49x | 1.72x | 1.69x | 1.4x |
EV/EBITDA | 13.43x | 14.24x | 15.51x | 17.9x |
Price to FCF (P/FCF) | 8.06x | 9.61x | 9.27x | 8.22x |
EV/FCF | 9.38x | 10.3x | 9.95x | 8.68x |
FCF Yield | 12.41% | 10.4% | 10.79% | 12.16% |